Candida Infections in Clinical Trials of Ixekizumab (Taltz), an Interleukin-17A Monoclonal Antibody, in Patients With Psoriasis or Psoriatic Arthritis

Bobonich, M; Young, MS; Parker, PA; Xu, W; Ridenour, TL

Bobonich, M (reprint author), Case Western Reserve Univ, Dept Dermatol, Sch Med, 11100 Euclid Ave, Cleveland, OH 44106 USA.

JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION, 2019; 11 (6): 250

Abstract

Interleukin-17 mediates immunity against pathogens such as Candida. Ixekizumab, an anti-interleukin-17A antibody, showed efficacy treating psoriasis (......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索